ArticlePloS one2017

Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.

Alexander C Dowell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.